Noncovalent assembly of anti-dendritic cell antibodies and antigens for evoking immune responses in vitro and in vivo

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2645-2655

  Flamar, Anne Laure ^a,b   Zurawski, Sandra ^a   Scholz, Felix ^c   Gayet, Ingrid ^a   Ni, Ling ^a   Li, Xiao Hua ^a   Klechevsky, Eynav ^a,e   Quinn, John ^d   Oh, SangKon ^a   Kaplan, Daniel H ^c   Banchereau, Jacques ^a   Zurawski, Gerard ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c UNIVERSITY OF MINNESOTA   (United States)

^d ICx Nomadics   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY; CELL ANTIGEN; CELL RECEPTOR; CELLULOSE; COHESIN; DENDRITIC CELL ANTIBODY; DENDRITIC CELL ANTIGEN; DENDRITIC CELL RECEPTOR; DENDRITIC CELL VACCINE; DOCKERIN; HYBRID PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; LANGERIN RECOMBINANT ANTIBODY; PROTEIN; RECOMBINANT ANTIBODY; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SECRETION; CONTROLLED STUDY; CYTOPLASM; DRUG CONJUGATION; DRUG TARGETING; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; MICROBIAL DEGRADATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIBODIES; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MOLECULAR TARGETED THERAPY; RECOMBINANT FUSION PROTEINS;

EID: 84865434232     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102390     Document Type: Article

References (33)

1. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
2. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
3. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
4. Delneste, Y., G. Magistrelli, J. Gauchat, J. Haeuw, J. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamura, J. Bonnefoy, and P. Jeannin. 2002. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17: 353-362.
5. Trumpfheller, C., J. S. Finke, C. B. López, T. M. Moran, B. Moltedo, H. Soares, Y. Huang, S. J. Schlesinger, C. G. Park, M. C. Nussenzweig, et al. 2006. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203: 607-617.
6. Caminschi, I., A. I. Proietto, F. Ahmet, S. Kitsoulis, J. Shin Teh, J. C. Lo, A. Rizzitelli, L. Wu, D. Vremec, S. L. van Dommelen, et al. 2008. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112: 3264-3273.
7. Igyártó, B. Z., K. Haley, D. Ortner, A. Bobr, M. Gerami-Nejad, B. T. Edelson, S. M. Zurawski, B. Malissen, G. Zurawski, J. Berman, and D. H. Kaplan. 2011. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35: 260-272.
8. Dudziak, D., A. O. Kamphorst, G. F. Heidkamp, V. R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H. W. Lee, C. G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111.
9. Tacken, P. J., I. J. de Vries, K. Gijzen, B. Joosten, D. Wu, R. P. Rother, S. J. Faas, C. J. Punt, R. Torensma, G. J. Adema, and C. G. Figdor. 2005. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 106: 1278-1285.
10. Ramakrishna, V., J. F. Treml, L. Vitale, J. E. Connolly, T. O'Neill, P. A. Smith, C. L. Jones, L. Z. He, J. Goldstein, P. K. Wallace, et al. 2004. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs antimelanoma T cell responses via multiple HLA molecules. J. Immunol. 172: 2845-2852.
11. Bozzacco, L., C. Trumpfheller, F. P. Siegal, S. Mehandru, M. Markowitz, M. Carrington, M. C. Nussenzweig, A. G. Piperno, and R. M. Steinman. 2007. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc. Natl. Acad. Sci. USA 104: 1289-1294.
12. Carvalho, A. L., F. M. Dias, J. A. Prates, T. Nagy, H. J. Gilbert, G. J. Davies, L. M. Ferreira, M. J. Romão, and C. M. Fontes. 2003. Cellulosome assembly revealed by the crystal structure of the cohesin-dockerin complex. Proc. Natl. Acad. Sci. USA 100: 13809-13814.
13. Bayer, E. A., J. P. Belaich, Y. Shoham, and R. Lamed. 2004. The cellulosomes: multienzyme machines for degradation of plant cell wall polysaccharides. Annu. Rev. Microbiol. 58: 521-554.
14. Bayer, E. A., E. Morag, and R. Lamed. 1994. The cellulosome - a treasure-trove for biotechnology. Trends Biotechnol. 12: 379-386.
15. Reddy, M. P., C. A. Kinney, M. A. Chaikin, A. Payne, J. Fishman-Lobell, P. Tsui, P. R. Dal Monte, M. L. Doyle, M. R. Brigham-Burke, D. Anderson, et al. 2000. Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J. Immunol. 164: 1925-1933.
16. Klechevsky, E., A. L. Flamar, Y. Cao, J. P. Blanck, M. Liu, A. O'Bar, O. Agouna-Deciat, P. Klucar, L. Thompson-Snipes, S. Zurawski, et al. 2010. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood 116: 1685-1697.
17. Bates, E. E., N. Fournier, E. Garcia, J. Valladeau, I. Durand, J. J. Pin, S. M. Zurawski, S. Patel, J. S. Abrams, S. Lebecque, et al. 1999. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 163: 1973-1983.
18. Ni, L., I. Gayet, S. Zurawski, D. Duluc, A. L. Flamar, X. H. Li, A. O'Bar, S. Clayton, A. K. Palucka, G. Zurawski, et al. 2010. Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses. J. Immunol. 185: 3504-3513.
19. Bobr, A., I. Olvera-Gomez, B. Z. Igyarto, K. M. Haley, K. A. Hogquist, and D. H. Kaplan. 2010. Acute ablation of Langerhans cells enhances skin immune responses. J. Immunol. 185: 4724-4728.
20. Zhu, Q., V. G. Zarnitsyn, L. Ye, Z. Wen, Y. Gao, L. Pan, I. Skountzou, H. S. Gill, M. R. Prausnitz, C. Yang, and R. W. Compans. 2009. Immunization by vaccinecoated microneedle arrays protects against lethal influenza virus challenge. Proc. Natl. Acad. Sci. USA 106: 7968-7973.
21. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779.
22. Junutula, J. R., H. Raab, S. Clark, S. Bhakta, D. D. Leipold, S. Weir, Y. Chen, M. Simpson, S. P. Tsai, M. S. Dennis, et al. 2008. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index. Nat. Biotechnol. 26: 925-932.
23. Achari, A., S. P. Hale, A. J. Howard, G. M. Clore, A. M. Gronenborn, K. D. Hardman, and M. Whitlow. 1992. 1.67-A X-ray structure of the B2 immunoglobulin-binding domain of streptococcal protein G and comparison to the NMR structure of the B1 domain. Biochemistry 31: 10449-10457.
24. Delves, P. J., I. M. Roitt, S. J. Martin, and D. R. Burton. 2006. Roitt's Essential Immunology. Blackwell Publishing.
25. Kostelny, S. A., M. S. Cole, and J. Y. Tso. 1992. Formation of a bispecific antibody by the use of leucine zippers. J. Immunol. 148: 1547-1553.
26. de Kruif, J., and T. Logtenberg. 1996. Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library. J. Biol. Chem. 271: 7630-7634.
27. Ridgway, J. B., L. G. Presta, and P. Carter. 1996. 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. 9: 617-621.
28. Lian, Q., S. J. Szarka, K. K. Ng, and S. L. Wong. 2003. Engineering of a staphylokinase-based fibrinolytic agent with antithrombotic activity and targeting capability toward thrombin-rich fibrin and plasma clots. J. Biol. Chem. 278: 26677-26686.
29. Pack, P., and A. Plückthun. 1992. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry 31: 1579-1584.
30. Fierobe, H. P., E. A. Bayer, C. Tardif, M. Czjzek, A. Mechaly, A. Bélaïch, R. Lamed, Y. Shoham, and J. P. Bélaïch. 2002. Degradation of cellulose substrates by cellulosome chimeras. Substrate targeting versus proximity of enzyme components. J. Biol. Chem. 277: 49621-49630.
31. Doherty, P. C., S. J. Turner, R. G. Webby, and P. G. Thomas. 2006. Influenza and the challenge for immunology. Nat. Immunol. 7: 449-455.
32. Ahmed, R., M. B. Oldstone, and P. Palese. 2007. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat. Immunol. 8: 1188-1193.
33. Jones, T. D., L. J. Crompton, F. J. Carr, and M. P. Baker. 2009. Deimmunization of monoclonal antibodies. Methods Mol. Biol. 525: 405-423 (xiv).